05.06.2020
Pathophysiology and clinical course indicate a therapeutic benefit of CRP apheresis.
You can read in our background rationale, why we consider CRP apheresis useful for COVID-19 patients.
We have also published this therapy option for COVID-19 patients in the Journal for Therapeutic Apheresis and Dialysis.